Kapp M - Search Results

1

Challenges to preventing infectious complications, decreasing re-hospitalizations, and reducing cost burden in long-term survivors after allogeneic hematopoietic stem cell transplantation.

Fuji S, Kapp M, Einsele H. Fuji S, et al. Among authors: kapp m. Semin Hematol. 2012 Jan;49(1):10-4. doi: 10.1053/j.seminhematol.2011.10.009. Semin Hematol. 2012. PMID: 22221780 Review.

2

Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation.

Fuji S, Löffler J, Savani BN, Einsele H, Kapp M. Fuji S, et al. Among authors: kapp m. Bone Marrow Transplant. 2017 May;52(5):657-662. doi: 10.1038/bmt.2016.306. Epub 2016 Dec 12. Bone Marrow Transplant. 2017. PMID: 27941771 Review.

3

Adoptive immunotherapy with virus-specific T cells.

Fuji S, Kapp M, Grigoleit GU, Einsele H. Fuji S, et al. Among authors: kapp m. Best Pract Res Clin Haematol. 2011 Sep;24(3):413-9. doi: 10.1016/j.beha.2011.06.003. Best Pract Res Clin Haematol. 2011. PMID: 21925094 Review.

4

Monitoring of pathogen-specific T-cell immune reconstitution after allogeneic hematopoietic stem cell transplantation.

Fuji S, Kapp M, Einsele H. Fuji S, et al. Among authors: kapp m. Front Immunol. 2013 Sep 17;4:276. doi: 10.3389/fimmu.2013.00276. Front Immunol. 2013. PMID: 24062744 Free PMC article. Review.

5

Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Fuji S, Kapp M, Einsele H. Fuji S, et al. Among authors: kapp m. Front Oncol. 2014 Apr 24;4:89. doi: 10.3389/fonc.2014.00089. eCollection 2014. Front Oncol. 2014. PMID: 24795865 Free PMC article. Review.

6

MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation.

Tomuleasa C, Fuji S, Cucuianu A, Kapp M, Pileczki V, Petrushev B, Selicean S, Tanase A, Dima D, Berindan-Neagoe I, Irimie A, Einsele H. Tomuleasa C, et al. Among authors: kapp m. Ann Hematol. 2015 Jul;94(7):1081-92. doi: 10.1007/s00277-015-2369-0. Epub 2015 Apr 22. Ann Hematol. 2015. PMID: 25900787 Review.

7

Systematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Fuji S, Einsele H, Savani BN, Kapp M. Fuji S, et al. Among authors: kapp m. Biol Blood Marrow Transplant. 2015 Oct;21(10):1707-13. doi: 10.1016/j.bbmt.2015.07.003. Epub 2015 Jul 11. Biol Blood Marrow Transplant. 2015. PMID: 26172477 Free article. Review.

8

Immunotherapy for opportunistic infections: Current status and future perspectives.

Fuji S, Löffler J, Einsele H, Kapp M. Fuji S, et al. Among authors: kapp m. Virulence. 2016 Nov 16;7(8):939-949. doi: 10.1080/21505594.2016.1207038. Epub 2016 Jul 6. Virulence. 2016. PMID: 27385102 Free PMC article. Review.

9

Cytomegalovirus disease in hematopoietic stem cell transplant patients: current and future therapeutic options.

Fuji S, Einsele H, Kapp M. Fuji S, et al. Among authors: kapp m. Curr Opin Infect Dis. 2017 Aug;30(4):372-376. doi: 10.1097/QCO.0000000000000375. Curr Opin Infect Dis. 2017. PMID: 28505028 Review.

10

Adoptive immunotherapy of HCMV infection.

Kapp M, Tan SM, Einsele H, Grigoleit G. Kapp M, et al. Cytotherapy. 2007;9(8):699-711. doi: 10.1080/14653240701656046. Epub 2007 Oct 4. Cytotherapy. 2007. PMID: 17917875 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters